In 1990, a paradigm shift occurred in the development of new medicines and treatments. An idea so big, that it was supposed to encompass the whole of medicine. It was to start initially at the level of pre-clinical and clinical trials and work all the way through the system to the care and management of…

Commentary The People’s Republic of China has a formidable reputation in the field of facial recognition technology. This technology, which is increasingly used in surveillance operations to control China’s population, is widespread and intrusive. Relying on this technology, the Chinese Communist Party (CCP) is developing its social credit system, which has become one of the…

The BGI Annual Report for 2020 says it is committed to promoting China’s globalization efforts and supports the Chinese Communist Party’s (CCP) “One Belt, One Road” strategy. The report shows how BGI expanded its operations across China, opened gene banks and research facilities in Xingjiang and Tibet, and is now serving customers in more than…

News Analysis This is the second of three articles that introduce readers to the research and mission of BGI Group, China’s leading genome sequencing company with customers around the globe. Its research involves collecting, studying, and altering human and animal genes to facilitate such things as biochemical weapons development and even customizing humans. The BGI…